Federal Circuit Orders Extra Mayo

Section 101

Last Wednesday we commented on a Delaware decision (Andrews, J.) applying the Federal Circuit’s Mayo analysis to find that a patent on a new dosing regimen for an old drug lacked patentable subject matter under 35 U.S.C. § 101.  Alice in Pharma Land.  Two days later, the Federal Circuit affirmed another Delaware decision (Stark, J.)…

Alice in Pharma Land

ANDA Litigation, Section 101, Supreme Court

Ever since the Supreme Court’s decision in Alice Corp. v. CLS Bank, 134 S.Ct. 2347 (2014), courts have churned out countless decisions holding patents invalid under 35 U.S.C. § 101 for claiming unpatentable subject matter.  Most of these patents have involved the application of well-known business methods by means of a computer.  In those cases,…